ARCHIVES

Phase III Xilonix Study Halted Following Unscheduled Analysis

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

NIH Proposes Stricter Rules On Extramural Research Financial Conflicts

May 21, 2010

ACS, SU2C Committ $20 Million For Lung Cancer Dream Team

January 31, 2014

FDA Approves SNDA For Gardasil For Anal Cancer And Precancerous Lesions

January 28, 2011

Senate Subcommittee Gives NCI 41.397 Billion for FY ‘87

August 8, 1986

NCI Program Announcements

May 5, 2000

House May Add $80 Million To NCI Budget For FY 1984

September 16, 1983